[ad_1]
Cisco Systems Inc. posted impressive fiscal fourth-quarter results Wednesday, and while company executives touted an AI boost, the real star of the show was its fat profit margins, driven by both a resurgence in enterprise orders and cost-cutting.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...